alexa A Brief Review Of Comorbidities Associated With Atopic Dermatitis
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

14th International Conference on Clinical and Experimental Dermatology
June 19-20, 2017 Philadelphia, USA

Lauren Bonomo, Alvaro J Rodriguez and Manrup K Hunjan
Icahn School of Medicine at Mount Sinai, USA
Posters & Accepted Abstracts: J Clin Exp Dermatol Res
DOI: 10.4172/2155-9554-C1-060
Background: Atopic dermatitis (AD) is known to be associated with other allergic diseases. These conditions include asthma, food allergy, and allergic rhinoconjunctivitis. AD typically occurs in early childhood with allergic comorbidities developing later in life in a serial fashion. This progression is termed the “atopic march” and is considered the classical presentation of atopic disease. However, recent evidence suggests that this paradigm may not hold true for a significant portion of patients with these conditions. Not only is the timing of development likely more complex than previously believed, the comorbidities associated with AD are possibly more numerous and varied. Methods: We conducted a systematic search of the literature on AD and associated extracutaneous disease. The two-step search involved a targeted search of PubMed and EMBASE and a hand search of all abstracts published in 5 key journals. The final yield was 65 articles, which consisted of 41 case-control studies (63.1%), 19 cohort studies (29.2%) and 5 meta-analyses (7.7%). Results: The results of this systematic review support the notion that atopic dermatitis is strongly associated with other atopic diseases, including asthma, hay fever, and allergic rhinoconjunctivitis. However, it also suggests that the classical paradigm of the “atopic march” does not apply to all patients with atopic dermatitis. There is likely a diversity of phenotypes for patterns of allergic disease. We found a major association between AD and neuropsychiatric disorders, particularly autism spectrum and attention deficit hyperactivity disorders. We found evidence that patients with AD may have an increased risk of developing lymphoma, squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). There was also a small body of evidence suggesting an increased risk for myocardial infarction, stroke and cardiovascular death. The evidence on autoimmune comorbidities was mixed, with the only significant association being a reduced risk of type 1 diabetes mellitus. Conclusion: Our analysis supports a significant association between AD and neuropsychiatric, cardiovascular and infectious disorders as well as increased risk for malignancies. Surprisingly, patients with AD had a decreased risk of developing type 1 diabetes mellitus.

Lauren Bonomo, BA, graduated with honors from Yale University and is now a Medical student at the Icahn School of Medicine at Mount Sinai. She is currently on a scholarly year, pursuing research in Icahn’s Department of Dermatology. She is particularly interested in inflammatory and autoimmune skin disease, including atopic dermatitis, psoriasis, vitiligo, and alopecia areata.

Email: [email protected]

image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version